Retraction notices

Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol

Type

Correction

Notice date

6/6/2016 0:00

Journal

Current Pharmaceutical Biotechnology

Publisher

Bentham Science Publishers

Notice DOI

10.2174/138920101709160606123055

Original paper DOI

10.2174/138920111794295774

Reasons

• Falsification/Fabrication of Data
• Investigation by Company/Institution
• Misconduct - Official Investigation(s) and/or Finding(s)
• Misconduct by Author

Matching venue names

Name match only, not an authoritative journal identifier.

• Current Pharmaceutical Biotechnology